17 мая 2019 г. · Pembrolizumab monotherapy (PD-L1 TPS ≥ 50%) and carboplatin plus taxane plus pembrolizumab combinatorial therapy are new first-line standards of care. |
The 272 patients with advanced or metastatic SCC were randomized to either nivolumab or docetaxel after having progressed on prior platinum-based chemotherapy. |
11 окт. 2024 г. · Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. |
Pembrolizumab, atezolizumab, and cemiplimab are approved as monotherapies for use in the first-line treatment of patients with NSCLC, PD-L1 expression of ≥ 50% ... |
This stage is usually treated with surgical removal of the tumor and lymph nodes followed by chemotherapy to kill any remaining cancer cells. If the tumor is ... Stages · Treatment · Metastasis · Causes & risk factors |
Novbeti > |
Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |